Catalyst Wire Dossier Catalyst Wire Dossier

Bosatria

mepolizumab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bosatria, covering 2009-07-29 to 2009-07-29. Get the full timeline:

Most recent: EMA Application withdrawn: Bosatria (Mepolizumab) — Glaxo Group Limited

See pricing